Neovasc (NVCN) to Release Earnings on Thursday

Neovasc (NASDAQ:NVCNGet Rating) (TSE:NVC) is set to post its quarterly earnings results after the market closes on Thursday, August 11th. Analysts expect Neovasc to post earnings of ($1.25) per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Neovasc (NASDAQ:NVCNGet Rating) (TSE:NVC) last posted its quarterly earnings data on Thursday, May 12th. The medical equipment provider reported ($3.01) EPS for the quarter, missing analysts’ consensus estimates of ($1.25) by ($1.76). Neovasc had a negative return on equity of 50.69% and a negative net margin of 1,192.20%. The firm had revenue of $0.61 million during the quarter, compared to the consensus estimate of $0.80 million.

Neovasc Stock Up 3.4 %

NVCN opened at $7.86 on Thursday. Neovasc has a one year low of $4.59 and a one year high of $21.56. The company has a debt-to-equity ratio of 0.27, a quick ratio of 12.50 and a current ratio of 12.88. The stock’s fifty day moving average is $6.03 and its 200-day moving average is $9.47. The company has a market capitalization of $21.26 million, a PE ratio of -0.65 and a beta of 2.30.

Analysts Set New Price Targets

Separately, initiated coverage on Neovasc in a research report on Monday. They set a “sell” rating on the stock.

Neovasc Company Profile

(Get Rating)

Neovasc Inc, a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina.

Recommended Stories

Earnings History for Neovasc (NASDAQ:NVCN)

Want More Great Investing Ideas?

Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with's FREE daily email newsletter.